- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Moderna Inc (MRNA)
Moderna Inc stock price live, this page displays NASDAQ MRNA stock exchange data. View the MRNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Moderna Inc real time stock price chart below.
What Is the Moderna Inc Stock Price Today?
The Moderna Inc stock price today is 27.35.
What Is the Stock Symbol for Moderna Inc?
The stock symbol for Moderna Inc is ""MRNA.""
What Stock Exchange Does Moderna Inc Trade On?
Moderna Inc is listed and trades on the NASDAQ stock exchange.
Is Moderna Inc a Good Stock to Buy?
Determining whether Moderna Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRNA quote. (ISIN: US60770K1079)
What Is the Moderna Inc Stock Price Today?
The Moderna Inc stock price today is 27.35.
What Is the Stock Symbol for Moderna Inc?
The stock symbol for Moderna Inc is ""MRNA.""
What Stock Exchange Does Moderna Inc Trade On?
Moderna Inc is listed and trades on the NASDAQ stock exchange.
Is Moderna Inc a Good Stock to Buy?
Determining whether Moderna Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRNA quote. (ISIN: US60770K1079)
27.35
-0.40(-1.44%)
Closed·
Pre Market
26.68-0.67(-2.45%)
·
Fair Value
An estimate of a Moderna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.81
27.93
52 wk Range
23.15
145.74
MRNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MRNA is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Moderna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.8127.93
52 wk Range
23.15145.74
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MRNA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Moderna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
47.64
Upside
+74.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
6 analysts have revised their earnings upwards for the upcoming period
Moderna Inc Company Profile
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Moderna Inc SWOT Analysis
mRNA Trailblaze | Moderna, a pioneer in mRNA technology, faces challenges as COVID-19 vaccine demand wanes. Explore its strategic pivot and diverse pipeline. |
Financial Crossroads | With revenue declining 52.75% in the last year, Moderna aims for cash break-even by 2028. Analyst price targets range from $45 to $155. |
Cancer Vaccine Promise | Delve into Moderna's cancer vaccine program, a potential $20 billion market opportunity, and its collaboration with Merck for melanoma treatment. |
Pipeline Diversity | Learn about Moderna's expansive portfolio beyond COVID-19, including respiratory vaccines, rare disease treatments, and latent virus prevention. |
Moderna Inc Earnings Call Summary for Q1/2025
- Moderna's Q1 2025 EPS of -$2.52 beat expectations, but revenue of $108M missed forecasts; stock fell 5.1% pre-market
- Revenue declined 35% YoY; company reduced costs by 19%, enhancing financial stability; ended Q1 with $8.4B in cash
- 2025 revenue guidance set at $1.5-$2.5B; targeting cost reductions of $1.4-$1.7B by 2027 and cash breakeven by 2028
- Advancing vaccine and oncology pipelines; upcoming launches include next-gen COVID vaccine and flu + COVID combination
- CEO prioritizes sales growth, late-stage pipeline focus, and cost efficiency; demand for COVID vaccination remains strong
Last Updated: 01/05/2025, 14:16
Read Full TranscriptCompare MRNA to Peers and Sector
Metrics to compare | MRNA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRNAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | 4.3x | −0.5x | |
PEG Ratio | −0.07 | −0.02 | 0.00 | |
Price/Book | 1.1x | 1.5x | 2.6x | |
Price / LTM Sales | 3.3x | 3.4x | 3.1x | |
Upside (Analyst Target) | 13.5% | 139.5% | 48.3% | |
Fair Value Upside | Unlock | 3.6% | 7.6% | Unlock |
Analyst Ratings
5 Buy
17 Hold
4 Sell
Ratings:
26 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 47.64
(+74.17% Upside)
Earnings
Latest Release
May 01, 2025
EPS / Forecast
-2.52 / -3.18
Revenue / Forecast
108.00M / 115.30M
People Also Watch
FAQ
What Stock Exchange Does Moderna Trade On?
Moderna is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Moderna?
The stock symbol for Moderna is "MRNA."
What Is the Moderna Market Cap?
As of today, Moderna market cap is 10.58B.
What Is Moderna's Earnings Per Share (TTM)?
The Moderna EPS (TTM) is -8.72.
When Is the Next Moderna Earnings Date?
Moderna will release its next earnings report on 30 Jul 2025.
From a Technical Analysis Perspective, Is MRNA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Moderna Stock Split?
Moderna has split 0 times.
How Many Employees Does Moderna Have?
Moderna has 5800 employees.
What is the current trading status of Moderna (MRNA)?
As of 13 Jun 2025, Moderna (MRNA) is trading at a price of 27.35, with a previous close of 27.35. The stock has fluctuated within a day range of 26.81 to 27.93, while its 52-week range spans from 23.15 to 145.74.
What Is Moderna (MRNA) Price Target According to Analysts?
The average 12-month price target for Moderna is USD47.63636, with a high estimate of USD198 and a low estimate of USD20. 5 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +74.17% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.